Display options
Cite
Das BK, Swamy AV, Koti BC, et al. Experimental evidence for use of . Heliyon. 2019;5(5):e01585doi: 10.1016/j.heliyon.2019.e01585.
Das, B. K., Swamy, A. V., Koti, B. C., & Gadad, P. C. (2019). Experimental evidence for use of . Heliyon, 5(5), e01585. https://doi.org/10.1016/j.heliyon.2019.e01585
Das, Bhrigu Kumar, et al. "Experimental evidence for use of ." Heliyon vol. 5,5 (2019): e01585. doi: https://doi.org/10.1016/j.heliyon.2019.e01585
Das BK, Swamy AV, Koti BC, Gadad PC. Experimental evidence for use of . Heliyon. 2019 May 08;5(5):e01585. doi: 10.1016/j.heliyon.2019.e01585. eCollection 2019 May. PMID: 31193009; PMCID: PMC6513775.
Copy Download .nbib Format: NLM
Share it on

Heliyon. 2019 May 08;5(5):e01585. doi: 10.1016/j.heliyon.2019.e01585. eCollection 2019 May.

Experimental evidence for use of .

Heliyon

Bhrigu Kumar Das, Ahm Viswanatha Swamy, Basavaraj C Koti, Pramod C Gadad

Affiliations

  1. KLE College of Pharmacy (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Vidyanagar, Hubballi, 580 031, Karnataka, India.
  2. Off-campus Basic and Applied Sciences Research Centre of KLE Academy of Higher Education and Research at KLE College of Pharmacy, Vidyanagar, Hubballi, 580 031, Karnataka, India.

PMID: 31193009 PMCID: PMC6513775 DOI: 10.1016/j.heliyon.2019.e01585

Abstract

Cancer is one of the major non-communicable diseases posing substantial challenges in both developing and developed countries. The options available for treatment of different cancer are associated with various limitations, including severe toxicity, drug resistance, poor outcomes and a high risk of relapse. Hence, an increased attention and necessity for screening of various phytochemicals from natural sources for superior and safer alternative has been ongoing for several decades. In recent years, phytochemicals like galantamine, erwinaze, rivastigmine, resveratrol from natural sources have been found to be important therapeutic targets for the treatment of various diseases including cancer, neurodegeneration, diabetes, and cardiovascular effects.

Keywords: Biochemistry; Cancer research; Cell biology; Evidence-based medicine; Molecular biology; Oncology

References

  1. Mutat Res. 1992 Jun 16;279(4):269-73 - PubMed
  2. Electrophoresis. 2005 Feb;26(4-5):943-6 - PubMed
  3. Int Immunopharmacol. 2005 Aug;5(9):1470-8 - PubMed
  4. Pharmacol Res. 2005 Dec;52(6):467-74 - PubMed
  5. J Cell Mol Med. 2010 Apr;14(4):840-60 - PubMed
  6. Neurosci Res. 2010 Dec;68(4):337-44 - PubMed
  7. Fitoterapia. 2011 Apr;82(3):369-74 - PubMed
  8. Mutat Res. 2011 May 18;722(1):62-8 - PubMed
  9. Anticancer Agents Med Chem. 2013 Feb;13(2):281-95 - PubMed
  10. Biosci Biotechnol Biochem. 2012;76(8):1518-22 - PubMed
  11. Neuropharmacology. 2013 Feb;65:1-11 - PubMed
  12. Biol Pharm Bull. 2013;36(1):23-30 - PubMed
  13. Asian Pac J Cancer Prev. 2012;13(10):5291-8 - PubMed
  14. Phytomedicine. 2013 Apr 15;20(6):512-20 - PubMed
  15. BMC Complement Altern Med. 2013 Sep 25;13:236 - PubMed
  16. JAMA. 2013 Nov 6;310(17):1842-50 - PubMed
  17. Phytomedicine. 2014 Feb 15;21(3):268-76 - PubMed
  18. Biotechnol Lett. 2014 Apr;36(4):685-91 - PubMed
  19. Brain Res. 2014 Mar 13;1552:41-54 - PubMed
  20. Pak J Biol Sci. 2013 Aug 15;16(16):770-8 - PubMed
  21. Front Pharmacol. 2014 Mar 11;5:40 - PubMed
  22. Lancet Oncol. 2014 Apr;15(5):489-538 - PubMed
  23. Lancet Oncol. 2014 May;15(6):e205-12 - PubMed
  24. Nat Prod Res. 2014;28(18):1454-66 - PubMed
  25. Front Oncol. 2014 Jul 21;4:126 - PubMed
  26. Eur J Med Chem. 2014 Oct 6;85:784-94 - PubMed
  27. Int J Med Chem. 2014;2014:835485 - PubMed
  28. CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 - PubMed
  29. J Pharm Biomed Anal. 2015 Nov 10;115:292-9 - PubMed
  30. Oncol Rep. 2015 Dec;34(6):3043-50 - PubMed
  31. Pharmacol Res. 2016 Jan;103:227-35 - PubMed
  32. Pharm Biol. 2017 Dec;55(1):1358-1367 - PubMed
  33. Avicenna J Phytomed. 2017 Mar-Apr;7(2):145-156 - PubMed
  34. Biomed Pharmacother. 2017 Jun;90:368-374 - PubMed
  35. JAMA. 2017 Jun 27;317(24):2532-2542 - PubMed
  36. J Cell Physiol. 2018 Mar;233(3):2434-2443 - PubMed
  37. Medicines (Basel). 2017 Nov 08;4(4):null - PubMed
  38. J Glob Oncol. 2018 Sep;(4):1-11 - PubMed
  39. J Basic Clin Physiol Pharmacol. 2018 Mar 28;29(2):107-122 - PubMed
  40. Molecules. 2018 Mar 16;23(3):null - PubMed
  41. Molecules. 2018 May 03;23(5):null - PubMed

Publication Types